Rate of development low in pharma?
A 2005 article in the NYU annual survey has the text:
In the biopharmaceutical industry, the rate of development is low. There is, thus, little fear that a patented invention will be replaced before the patent's statutory life expires.
What can one say?
Elsewhere, the goal of the incentives patent law is attempting to create -- to encourage inventions of patentable quality.
In the biopharmaceutical industry, the rate of development is low. There is, thus, little fear that a patented invention will be replaced before the patent's statutory life expires.
What can one say?
Elsewhere, the goal of the incentives patent law is attempting to create -- to encourage inventions of patentable quality.
posted by Lawrence B. Ebert at 4:53 PM
0 Comments:
Post a Comment
<< Home